Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | HTR6 | P50406 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15404492 | 0.86 | POLB (0.54) | POLBCYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL31148931 | 0.83 | POLB (0.48) | POLBCYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL9364060 | 0.83 | POLB (0.48) | POLBCYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL13268417 | 0.82 | BCAT2 (0.42) | POLBCYP1A2CYP2C19MEN1KMT2A | |
| SCHEMBL9745499 | 0.81 | CYP1A2 (0.48) | POLBCYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL28193046 | 0.80 | POLB (0.46) | POLBCYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL14958316 | 0.80 | CYP1A2 (0.50) | POLBCYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL28157583 | 0.80 | POLB (0.46) | POLBCYP1A2CYP2C9CYP2C19MEN1 | |
| SCHEMBL28124089 | 0.79 | HSD11B1 (0.42) | POLBCYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL7470086 | 0.79 | POLB (0.44) | POLBCYP1A2CYP2C9CYP2C19MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6558736-B2 | Vapor deposition in vacuum | THE TRUSTEES OF PRINCETON UNIVERSITY | 2003-05-06 | — | — | US | claimed |
| US-20020155230-A1 | Low pressure vapor phase deposition of organic thin films | FORREST STEPHEN R (US) | 2002-10-24 | — | — | US | claimed |
| EP-1032722-A4 | LOW PRESSURE VAPOR PHASE DEPOSITION OF ORGANIC THIN FILMS | UNIV PRINCETON (US) | 2001-09-12 | — | — | EP | claimed |
| US-20010002279-A1 | Low pressure vapor phase deposition of organic thin films | FORREST STEPHEN R (US) | 2001-05-31 | — | — | US | claimed |
| EP-1032722-A1 | LOW PRESSURE VAPOR PHASE DEPOSITION OF ORGANIC THIN FILMS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0828867-A4 | METHOD AND APPARATUS USING ORGANIC VAPOR PHASE DEPOSITION FOR THE GROWTH OF ORGANIC THIN FILMS WITH LARGE OPTICAL NON-LINEARITIES | UNIV PRINCETON (US) | 1999-10-27 | — | — | EP | claimed |
| WO-1999025894-A1 | LOW PRESSURE VAPOR PHASE DEPOSITION OF ORGANIC THIN FILMS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1999-05-27 | — | — | WO | claimed |
| EP-0828867-A2 | METHOD AND APPARATUS USING ORGANIC VAPOR PHASE DEPOSITION FOR THE GROWTH OF ORGANIC THIN FILMS WITH LARGE OPTICAL NON-LINEARITIES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1998-03-18 | — | — | EP | claimed |
| WO-1996037639-A2 | METHOD AND APPARATUS USING ORGANIC VAPOR PHASE DEPOSITION FOR THE GROWTH OF ORGANIC THIN FILMS WITH LARGE OPTICAL NON-LINEARITIES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1996-11-28 | — | — | WO | claimed |
| US-5554220-A | Method and apparatus using organic vapor phase deposition for the growth of organic thin films with large optical non-linearities | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1996-09-10 | — | — | US | claimed |
| CN-102786373-A | Synthetic method of diazomethane compound | SHENZHEN IPI BIOLOG TECHNOLOGY CO LTD | 2012-11-21 | — | — | CN | disclosed |
| EP-1519937-A1 | PROCESS AND INTERMEDIATES FOR MAKING NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHIBITORS | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2005-04-06 | — | — | EP | disclosed |
| US-6759533-B2 | NOVEL INTERMEDIATES FOR THE SYNTHESIS OF CERTAIN NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2004-07-06 | — | — | US | disclosed |
| WO-2004002989-A1 | PROCESS AND INTERMEDIATES FOR MAKING NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHIBITORS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2004-01-08 | — | — | WO | disclosed |
| US-20040002489-A1 | Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2004-01-01 | — | — | US | disclosed |
| WO-1996037639-A2 | METHOD AND APPARATUS USING ORGANIC VAPOR PHASE DEPOSITION FOR THE GROWTH OF ORGANIC THIN FILMS WITH LARGE OPTICAL NON-LINEARITIES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1996-11-28 | — | — | WO | disclosed |
| US-5554220-A | Method and apparatus using organic vapor phase deposition for the growth of organic thin films with large optical non-linearities | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1996-09-10 | — | — | US | disclosed |
| EP-0023785-A2 | Quinoxalinyloxyphenoxyalkane carboxylic acid derivatives, their preparation and their use as herbicides | ICI AUSTRALIA LIMITED (AU) | 1981-02-11 | — | — | EP | disclosed |
| EP-0013145-A2 | Substituted anilinopyridines, processes for their preparation and intermediates for use therein, compositions and herbicidal use thereof | ICI AUSTRALIA LIMITED (AU) | 1980-07-09 | — | — | EP | disclosed |
| US-4116965-A | STYRYL DYESTUFFS CONTAINING CERTAIN AMINO, CYANOPYRIDINE MOIETIES | CIBA-GEIGY CORPORATION (US) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040002489-A1 | Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors | REV1, POLR2E, POLR2H | POLB 13/4885CYP1A2 1099/4885CYP2C9 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.